Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Sep 06, 2021 6:08pm
233 Views
Post# 33817189

RE:TOP TEN BULLBOARDS

RE:TOP TEN BULLBOARDS
Comments from another pharma stock bullboard. Funny how outlooks can be so common or appropriate from one stock to another without names being used:


"It is usually the sign of a champion. It isn't about how many times you get knocked down, it's about how many times you get back up.

Our recent additions to the team make us stronger but also take some of the load off of our existing BOD. That in itself makes everyone's job a little easier and reduces the possibility of anything falling through the cracks.

I foresee multiple positive catalysts between now and the end of the year. Delays do not concern me. We are talking about governmental agencies and red tape. No government or agency moves as quickly as the private sector. Especially regarding health care. As an investor, if you don't realize this, you need to get out of biotech. It will break your heart every time.

Just like everything and everybody, when success shows up, all want to jump on the bandwagon. This is true about sport teams, stocks, politicians etc.

It is said that success has many fathers and failure is an orphan. With our first success we can expect MacLeod's, Canada, UK, Europe, Latin America etc. to come calling.

Along with that will come big pharma. Expect a bidding war. Unless there's a big pharma currently in negotiations and gets a deal done. If I were a big pharma company, and I realized that it was inevitable that this drug would be approved for something somewhere, I would cut a deal just based on all the other indications we address. It may be licensing, partnership or buyout.

Buying more at every opportunity!"

<< Previous
Bullboard Posts
Next >>